In light of evolving evidence that some patients with node-positive estrogen receptor–positive (ER+) disease may receive less benefit from chemotherapy, this study reports 12-year outcomes of the ...
Adjuvant chemotherapy is considered standard care for patients with lymph node (LN) –positive and high-risk LN-negative early breast cancer (EBC). Although chemotherapy-associated toxicities are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results